Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Wanbin Xu"'
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Objectives: This study aims to explore the weight loss effect and safety of semaglutide as a conventional anti-obesity drug systematically in obese or overweight patients without diabetes.Methods: The randomized controlled trials (RCTs) of semaglutid
Externí odkaz:
https://doaj.org/article/ca6e4c4be99e4aa89cae59c0e81e7c2c
Autor:
Shuang Guo, Xudong Gong, Abdullajon Odilov, Fuqiang Zhu, Tianwen Hu, Dehui Jiang, Xiangrui Jiang, Wanbin Xu, Jingshan Shen, Mingjun Wu
Publikováno v:
Organic Process Research & Development. 25:2447-2452
The development of an industrially scalable synthetic route for 5,7-dichlorotetrahydroisoquinoline-6-carboxylic acid (1), a key starting material for lifitegrast, is described. This route includes ...
Autor:
Xudong Gong, Wanbin Xu, Yuanchao Xie, Sun Changliang, Yan Zhang, Melkamu Alemu Abame, Haji Akber Aisa, Fuqiang Zhu, Wenqiang Shi, Jingshan Shen
Publikováno v:
The Journal of organic chemistry. 85(4)
A novel synthetic route for making (-)-CBD and its derivatives bearing various C4'-side chains is developed by a late-stage diversification method. Starting from commercially available phloroglucinol, the key intermediate (-)-CBD-2OPiv-OTf is efficie
Autor:
Wanbin Xu, Xudong Gong, Odilov, Abdullajon, Tianwen Hu, Xiangrui Jiang, Fuqiang Zhu, Shuang Guo, Dehui Jiang, Mingjun Wu, Jingshan Shen
Publikováno v:
Organic Process Research & Development; 11/19/2021, Vol. 25 Issue 11, p2447-2452, 6p